[Reuters] – The U.S. Supreme Court said on Monday it would leave intact a $142 million jury verdict against Pfizer Inc over its marketing of the epilepsy drug Neurontin. A jury in Massachusetts found in 2010 that …
Read more on this.
Pfizer Inc. (PFE), currently valued at $204.96B, began … [visit site to read more]
Similar posts:- Pfizer Vs. Novartis: A New Era In Breast Cancer Treatment – Pfizer Inc. (NYSE:PFE)
- Company Update: JPMorgan Chase & Co (NYSE:JPM) – JPMorgan’s $13bn settlement likely to leave top executives ‘off the hook’
- Zimbabwe – last to leave, Never Mind Turning Off the Lights – They’re Already Off
